– – GN Store Nord
– – GN Hearing
– – GN Audio
Quotes from executive management
Gitte Aabo, CEO of GN Hearing, comments: “Unfortunately, we had to revise our financial guidance for the year due to product launch delays. However, we firmly believe that the transformation we have initiated of our R&D setup will secure the new product launches in 2022 that enables our continued journey towards delivering more natural and individualized hearing instruments. Further, we are very pleased to finally see the draft over-the-counter regulation, which will open new market opportunities, and we look forward to having the opportunity to comment on FDA’s proposal.”
René Svendsen-Tune, CEO of GN Audio, comments: “We see continued very strong demand across our segments and given the increasing challenges and volatility related to the global shortage of certain components, we are very satisfied with the growth achieved in the quarter on top of the very strong base from last year. However, the increased volatility related to the global supply situation has forced us to revise the guidance. We are naturally disappointed by the guidance revision, but we continue to be very comfortable with the underlying demand and trends, which bodes well for our business in the years to come. With launches of the new Jabra Elite line-up of true wireless earbuds, the launch of Jabra Evolve2 75 as well as our expanded Jabra PanaCast conference video portfolio, GN Audio continues to offer an industry leading product portfolio.”
Financial overview Q3 2021
GN Hearing | GN Audio | GN Store Nord* | |||||||
DKK million | Q3 2021 | Q3 2020 | Growth | Q3 2021 |
Q3 2020 | Growth | Q3 2021 |
Q3 2020 | Growth |
Revenue | 1,347 | 1,318 | 2% | 2,440 | 2,421 | 1% | 3,787 | 3,739 | 1% |
Organic growth | 4% | -11% | 1% | 72% | 2% | 29% | |||
Gross profit | 891 | 859 | 4% | 1,222 | 1,239 | -1% | 2,113 | 2,098 | 1% |
Gross profit margin | 66.1% | 65.2% | +0.9%p | 50.1% | 51.2% | -1.1%p | 55.8% | 56.1% | -0.3%p |
EBITA | 173 | 169 | 2% | 488*** | 550** | -11% | 625*** | 681** | -8% |
EBITA margin | 12.8% | 12.8% | 0%p | 20.0%*** | 22.7%** | -2.7%p | 16.5%*** | 18.2%** | -1.7%p |
Earnings per share (EPS) – DKK | 3.46*** | 4.09** | -15% | ||||||
Free cash flow excl. M&A | 340 | 47 | 623% | 281 | 592 | -53% | 493 | 612 | -19% |
Cash conversion | 197% | 28% | +169%p | 59% | 89% | -30%p | 81% | 77% | +4%p |
* Including “Other”, ** Excluding gain of DKK 114 million from legal settlements and litigation |
*** Excluding transaction related costs of DKK 14 million associated with the acquisition of SteelSeries
Teleconference
GN Store Nord will host a teleconference at 11.00 a.m. CET today. Please visit www.gn.com/investor to access the teleconference. Presentation material will be available on the website prior to the start of the teleconference.
For further information, please contact:
Investors and analysts
Henriette Wennicke
Vice President – Investor Relations & Treasury
Tel: +45 45 75 03 33
Or
Rune Sandager
Director – Investor Relations & Treasury
Tel: +45 45 75 92 57
Press and the media
Lars Otto Andersen-Lange
Head of Media Relations & Corporate Public Affairs
Tel: +45 45 75 02 55
About GN Group
The GN Group enables people to Hear More, Do More and Be More through its intelligent hearing, audio and video collaboration solutions. Inspired by people and driven by our innovation leadership, we leverage technological synergies to deliver unique and increasingly individualized user experiences in our products and solutions.
150 years ago, GN was founded with a truly innovative and global mindset. Today, we honor that legacy with world-leading expertise in the human ear, sound and video processing, wireless technology, miniaturization and collaborations with leading technology partners. GN’s solutions are marketed by the brands ReSound, Beltone, Interton, Jabra, BlueParrott and FalCom in 100 countries. Founded in 1869, the GN Group employs 6,500 people and is listed on Nasdaq Copenhagen (GN.CO).
Visit our homepage GN.com – and connect with us on LinkedIn, Facebook and Twitter.
Attachments
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq:…
NEW YORK, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed”…
Proposed merger would add a differentiated Phase 3 TROP2 Antibody-drug Conjugate (ADC) to the combined…
HALF-YEAR FINANCIAL REPORT AS OF JUNE 30, 2024 December 27, 2024, 6.00 p.m. Safe Group announces…
GRANTS, NEW MEXICO, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC: BGXX) (“Bright…
BOSTON, Dec. 27, 2024 /PRNewswire/ -- Judge Baker Children's Center d/b/a The Baker Center for…